Phase II study of cabozantinib in patients with progressive glioblastoma: Subset analysis of patients naive to antiangiogenic therapy

Patrick Y. Wen, Jan Drappatz, John De Groot, Michael D. Prados, David A. Reardon, David Schiff, Marc Chamberlain, Tom Mikkelsen, Annick Desjardins, Jaymes Holland, Jerry Ping, Ron Weitzman, Timothy F. Cloughesy

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of cabozantinib in patients with progressive glioblastoma: Subset analysis of patients naive to antiangiogenic therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences